article thumbnail

JOGO Health Opens Wefunder Campaign to Transform Pain Management

American Entrepreneurship

JOGO is the first-ever digital therapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases. Silverman and the late Joseph Brudny, M.D., the former Director of the Sensory Feedback Unit at ICD Research and Rehabilitation Center in Manhattan, were the original pioneers of EMG biofeedback in the 1970s.

health 105
article thumbnail

NJEDA Names Inaugural New Jersey Innovation Fellows Cohort

American Entrepreneurship

The company will focus on building its digital proprietary platform and easy-to-use digital application. Thrivio Health, North Bergen – $400,000 Thrivio Health offers an AI-driven healthcare platform and digital therapeutics for primary care, urgent care, mental health, and pediatric care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

Digital therapeutics will rewrite the future of healthcare. Digital therapeutics is perhaps the most innovative development in healthcare today and has the potential to dramatically change how care is delivered.

article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

Psychedelic medicine is spawning new companies in every part of the healthcare and life sciences ecosystem, including areas within drug discovery, manufacturing, clinics and retreats, telemedicine and other digital therapeutics, as well as consumer packaged goods.

article thumbnail

Atommerce wants to scale its mental health platform with $16.7M funding

TechCrunch

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. million Series B, which was three times oversubscribed within two months. In addition, the proceeds will be used to increase its headcount.

health 83
article thumbnail

Biofourmis hits unicorn status after $300m Series D funding

AsiaTechDaily

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?

article thumbnail

11 investors predict a colorful, if difficult, future for psychedelic startups

TechCrunch

Our overall focus is and has always been on central nervous system (CNS), and we are agnostic as to the modality, be it psychedelic drug development, other pharmacological approaches, medtech devices, or digital therapeutics.

startup 99